The latest prescription weight loss craze is a once-weekly injection of Wegovy (semaglutide) at a cost of over $1,400 per month. Wegovy is a higher dosage version of Ozempic, a drug also produced by big pharma giant Novo Nordisk A/S that was approved for the treatment of type 2 diabetes in 2017. Wegovy was approved for weight loss by the United States FDA in 2021.
Semaglutide works as a GLP-1 receptor agonist, which means that it acts like a compound that we make in our body known as human glucagon-like peptide-1 (GLP-1). Semaglutide is chemically 94% identical to human GLP-1. But it behaves much differently (discussed below) and that creates potential problems.

High Cholesterol

High Cholesterol

High Cholesterol What is cholesterol? Cholesterol is a fatty substance in the body that serves several vital roles. It is a building block for various hormones and bile acids; and it plays a major role in stabilizing cell membranes. While proper cholesterol levels are...

Parkinson’s Disease

Parkinson’s Disease

Parkinson’s DiseaseIntroduction Parkinson’s disease is a degenerative brain disorder caused by damage to an area of the brain responsible for controlling muscle tension and movement. The damaged brain cells in this region are unable to produce sufficient dopamine, an...

Signup For Our Weekly Newsletter

These are critical times in our quest for good / safe health practices...

Join our mailing list to receive the latest news and articles from Doctor Murray

You have Successfully Subscribed!